biotinylated secondary goat anti rabbit fab fragments (Jackson Immuno)
Jackson Immuno is a verified supplier 
93
Structured Review
Jackson Immuno
biotinylated secondary goat anti rabbit fab fragments
Biotinylated Secondary Goat Anti Rabbit Fab Fragments, supplied by Jackson Immuno, used in various techniques. Bioz Stars score: 93/100, based on 24 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/biotinylated+secondary+goat+anti+rabbit+fab+fragments/Biotin-SP+(long+spacer)+AffiniPure+Fab+Fragment+Goat+Anti-Rabbit+IgG/us12590953-893-1-7
Average 93 stars, based on 24 article reviews
Biotinylated Secondary Goat Anti Rabbit Fab Fragments, supplied by Jackson Immuno, used in various techniques. Bioz Stars score: 93/100, based on 24 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/biotinylated+secondary+goat+anti+rabbit+fab+fragments/Biotin-SP+(long+spacer)+AffiniPure+Fab+Fragment+Goat+Anti-Rabbit+IgG/us12590953-893-1-7
Average 93 stars, based on 24 article reviews
biotinylated secondary goat anti rabbit fab fragments - by Bioz Stars,
2026-09
93/100 stars
Images
Related Articles
Blocking Assay:Article Title: SALL4 mediates teratogenicity as a thalidomide-dependent cereblon substrate. Article Snippet: Celgene Corporation, San Diego, CA, USA.. *e-mail: pchamberlain@celgene.com Thalidomide was first marketed in the 1950s, when it found use as a mild sedative and in the treatment of morning sickness, among other indications1,2.. This led to a global epidemic of severe birth defects until it was established that thalidomide is a potent teratogen, with the most notable birth defect in surviving infants being phocomelia characterized by shortened or absent limbs3–6. Next-Generation Sequencing:Article Title: SALL4 mediates teratogenicity as a thalidomide-dependent cereblon substrate. Article Snippet: Celgene Corporation, San Diego, CA, USA.. *e-mail: pchamberlain@celgene.com Thalidomide was first marketed in the 1950s, when it found use as a mild sedative and in the treatment of morning sickness, among other indications1,2.. This led to a global epidemic of severe birth defects until it was established that thalidomide is a potent teratogen, with the most notable birth defect in surviving infants being phocomelia characterized by shortened or absent limbs3–6. Article Title: Methods for screening cereblon modifying compounds Article Snippet: For ZAFP91 staining on rabbit tissues, the following blocking steps were included: 1% T-X100 in TBS for 30 min, 2% normal goat serum plus 1% BSA in TBS for 30 min, goat anti-rabbit Fab fragments-unconjugated (JacksonImmunoResearch; cat#111-007-003) diluted 1/10 in TBS 1% NGS for 60 minutes, followed by primary ZFP91 antibody diluted in TBS with 2% NGS plus 1% BSA for 45 min incubation. .. A Article Title: Methods for screening cereblon modifying compounds Article Snippet: For ZAFP91 staining on rabbit tissues, the following blocking steps were included: 1% T-X100 in TBS for 30 min, 2% normal goat serum plus 1% BSA in TBS for 30 min, goat anti-rabbit Fab fragments-unconjugated (JacksonImmunoResearch; cat #111-007-003) diluted 1/10 in TBS 1% NGS for 60 minutes, followed by primary ZFP91 antibody diluted in TBS with 2% NGS plus 1% BSA for 45 min incubation. .. A Incubation:Article Title: SALL4 mediates teratogenicity as a thalidomide-dependent cereblon substrate. Article Snippet: Celgene Corporation, San Diego, CA, USA.. *e-mail: pchamberlain@celgene.com Thalidomide was first marketed in the 1950s, when it found use as a mild sedative and in the treatment of morning sickness, among other indications1,2.. This led to a global epidemic of severe birth defects until it was established that thalidomide is a potent teratogen, with the most notable birth defect in surviving infants being phocomelia characterized by shortened or absent limbs3–6. |